News

The Trump administration on Monday asked the Supreme Court to allow it to resume the deportations of nearly 200 Venezuelan migrants detained in Texas, requesting that the court lift its order from ...
On Saturday, Warner Bros.’ “Sinners” reached a box office milestone that no original film has achieved in eight years: $200 million in the U.S. and Canada. Driven by critical and audience ...
Stock market indexes soared on Thursday amid optimism on Wall Street after the Trump administration indicated progress toward easing global trade tensions with a deal with the United Kingdom.
Macquarie reveals the ASX 200 shares that are likely to feel a tailwind from the 90-day tariff deal. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...
Nearly 200 students have been rushed into quarantine in North Dakota over fears they were exposed to measles. The under-18s had all been in school buses or on campus at elementary, middle and ...
More than 200 suspected child sexual abuse offenders were arrested as part of a nationwide crackdown, the Department of Justice confirmed on May 7. Over five days, authorities arrested 205 alleged ...
Scots have been enjoying a long-awaited heatwave in recent weeks, with temperatures soaring well above 20C in widespread areas of the country. But along with the heat comes the urge to invest in ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
billboard global 200 the week's most popular songs based on streaming and sales activity from over 200 territories around the world — including the united states — as tracked by luminate. the ...
Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically, or ...
A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...